Azimuth Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-4,480
| Closed | -$234K | – | 279 |
|
|
2019
Q1 | $234K | Buy |
+4,480
| New | +$234K | 0.02% | 267 |
|
|
2018
Q4 | – | Sell |
-4,000
| Closed | -$201K | – | 284 |
|
|
2018
Q3 | $201K | Sell |
4,000
-120
| -3% | -$6.03K | 0.01% | 283 |
|
|
2018
Q2 | $208K | Hold |
4,120
| – | – | 0.02% | 279 |
|
|
2018
Q1 | $201K | Sell |
4,120
-50,596
| -92% | -$2.47M | 0.01% | 280 |
|
|
2017
Q4 | $2.43M | Buy |
54,716
+8,288
| +18% | +$367K | 0.18% | 156 |
|
|
2017
Q3 | $2.36M | Sell |
46,428
-14,856
| -24% | -$754K | 0.18% | 155 |
|
|
2017
Q2 | $3.3M | Buy |
61,284
+1,037
| +2% | +$55.9K | 0.26% | 134 |
|
|
2017
Q1 | $3.18M | Buy |
60,247
+2,320
| +4% | +$122K | 0.26% | 131 |
|
|
2016
Q4 | $2.79M | Sell |
57,927
-1,311
| -2% | -$63.1K | 0.24% | 140 |
|
|
2016
Q3 | $3.19M | Buy |
59,238
+514
| +0.9% | +$27.7K | 0.28% | 118 |
|
|
2016
Q2 | $3.18M | Sell |
58,724
-1,600
| -3% | -$86.7K | 0.28% | 119 |
|
|
2016
Q1 | $3.06M | Buy |
60,324
+4,748
| +9% | +$241K | 0.29% | 113 |
|
|
2015
Q4 | $2.8M | Buy |
55,576
+4,944
| +10% | +$249K | 0.27% | 126 |
|
|
2015
Q3 | $2.43M | Sell |
50,632
-7,008
| -12% | -$337K | 0.25% | 134 |
|
|
2015
Q2 | $3M | Buy |
57,640
+1,164
| +2% | +$60.6K | 0.29% | 114 |
|
|
2015
Q1 | $3.26M | Buy |
56,476
+27,512
| +95% | +$1.59M | 0.32% | 107 |
|
|
2014
Q4 | $1.55M | Buy |
28,964
+4,368
| +18% | +$233K | 0.16% | 161 |
|
|
2014
Q3 | $1.41M | Buy |
+24,596
| New | +$1.41M | 0.16% | 165 |
|